Biogen Return On Asset vs. Price To Book
| BIIB Stock | USD 174.63 3.19 1.79% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.5 | 0.69 |
|
|
For Biogen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biogen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biogen Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biogen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biogen Inc over time as well as its relative position and ranking within its peers.
Biogen's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Biogen Revenue Breakdown by Earning Segment
By analyzing Biogen's earnings estimates, investors can diagnose different trends across Biogen's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.192 | Earnings Share 10.77 | Revenue Per Share | Quarterly Revenue Growth 0.028 | Return On Assets |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biogen Inc Price To Book vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biogen's current stock value. Our valuation model uses many indicators to compare Biogen value to that of its competitors to determine the firm's financial worth. Biogen Inc is rated below average in return on asset category among its peers. It is rated below average in price to book category among its peers fabricating about 24.92 of Price To Book per Return On Asset. As of January 6, 2026, Price To Book Ratio is expected to decline to 1.46. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biogen's earnings, one of the primary drivers of an investment's value.Biogen's Earnings Breakdown by Geography
Biogen Price To Book vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Biogen |
| = | 0.0575 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Biogen |
| = | 1.43 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Biogen Price To Book Comparison
Biogen is currently under evaluation in price to book category among its peers.
Biogen Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biogen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biogen will eventually generate negative long term returns. The profitability progress is the general direction of Biogen's change in net profit over the period of time. It can combine multiple indicators of Biogen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -122.6 M | -116.5 M | |
| Operating Income | 2.9 B | 1.6 B | |
| Income Before Tax | 2.2 B | 1.6 B | |
| Total Other Income Expense Net | -525.9 M | -499.6 M | |
| Net Income | 1.9 B | 1.3 B | |
| Income Tax Expense | 314.9 M | 395.2 M | |
| Net Income Applicable To Common Shares | 3.5 B | 2 B | |
| Net Income From Continuing Ops | 1.9 B | 2.8 B | |
| Non Operating Income Net Other | 706.7 M | 742 M | |
| Interest Income | 77.7 M | 106.2 M | |
| Net Interest Income | -210.1 M | -220.6 M | |
| Change To Netincome | -1.3 B | -1.3 B | |
| Net Income Per Share | 10.08 | 10.59 | |
| Income Quality | 1.59 | 1.55 | |
| Net Income Per E B T | 0.98 | 0.92 |
Biogen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biogen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biogen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biogen's important profitability drivers and their relationship over time.
Biogen Earnings Estimation Breakdown
The calculation of Biogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Biogen is estimated to be 3.54 with the future projection ranging from a low of 2.83 to a high of 4.15. Please be aware that this consensus of annual earnings estimates for Biogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
2.83 Lowest | Expected EPS | 4.15 Highest |
Biogen Earnings Projection Consensus
Suppose the current estimates of Biogen's value are higher than the current market price of the Biogen stock. In this case, investors may conclude that Biogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Biogen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 35 | 85.82% | 0.0 | 3.54 | 10.77 |
Biogen Earnings per Share Projection vs Actual
Actual Earning per Share of Biogen refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Biogen Inc predict the company's earnings will be in the future. The higher the earnings per share of Biogen, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Biogen Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Biogen, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Biogen should always be considered in relation to other companies to make a more educated investment decision.Biogen Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Biogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-10-29 | 2025-09-30 | 3.85 | 4.81 | 0.96 | 24 | ||
2025-07-31 | 2025-06-30 | 3.88 | 5.47 | 1.59 | 40 | ||
2025-05-01 | 2025-03-31 | 2.95 | 3.02 | 0.07 | 2 | ||
2025-02-12 | 2024-12-31 | 3.36 | 3.44 | 0.08 | 2 | ||
2024-10-30 | 2024-09-30 | 3.79 | 4.08 | 0.29 | 7 | ||
2024-08-01 | 2024-06-30 | 4.03 | 5.28 | 1.25 | 31 | ||
2024-04-24 | 2024-03-31 | 3.45 | 3.67 | 0.22 | 6 | ||
2024-02-13 | 2023-12-31 | 3.18 | 3.3 | 0.12 | 3 | ||
2023-11-08 | 2023-09-30 | 3.97 | 4.36 | 0.39 | 9 | ||
2023-07-25 | 2023-06-30 | 3.77 | 4.02 | 0.25 | 6 | ||
2023-04-25 | 2023-03-31 | 3.28 | 3.4 | 0.12 | 3 | ||
2023-02-15 | 2022-12-31 | 3.48 | 4.05 | 0.57 | 16 | ||
2022-10-25 | 2022-09-30 | 4.14 | 4.77 | 0.63 | 15 | ||
2022-07-20 | 2022-06-30 | 4.06 | 5.25 | 1.19 | 29 | ||
2022-05-03 | 2022-03-31 | 4.38 | 4.38 | 0.0 | 0 | ||
2022-02-03 | 2021-12-31 | 3.38 | 3.39 | 0.01 | 0 | ||
2021-10-20 | 2021-09-30 | 4.09 | 4.77 | 0.68 | 16 | ||
2021-07-22 | 2021-06-30 | 4.54 | 5.68 | 1.14 | 25 | ||
2021-04-22 | 2021-03-31 | 5.04 | 5.34 | 0.3 | 5 | ||
2021-02-03 | 2020-12-31 | 4.87 | 4.58 | -0.29 | 5 | ||
2020-10-21 | 2020-09-30 | 8.04 | 8.84 | 0.8 | 9 | ||
2020-07-22 | 2020-06-30 | 8.03 | 10.26 | 2.23 | 27 | ||
2020-04-22 | 2020-03-31 | 7.73 | 9.14 | 1.41 | 18 | ||
2020-01-30 | 2019-12-31 | 8.02 | 8.34 | 0.32 | 3 | ||
2019-10-22 | 2019-09-30 | 8.27 | 9.17 | 0.9 | 10 | ||
2019-07-23 | 2019-06-30 | 7.53 | 9.15 | 1.62 | 21 | ||
2019-04-24 | 2019-03-31 | 6.87 | 6.98 | 0.11 | 1 | ||
2019-01-29 | 2018-12-31 | 6.73 | 6.99 | 0.26 | 3 | ||
2018-10-23 | 2018-09-30 | 6.78 | 7.4 | 0.62 | 9 | ||
2018-07-24 | 2018-06-30 | 5.21 | 5.8 | 0.59 | 11 | ||
2018-04-24 | 2018-03-31 | 5.94 | 6.05 | 0.11 | 1 | ||
2018-01-25 | 2017-12-31 | 5.45 | 5.26 | -0.19 | 3 | ||
2017-10-24 | 2017-09-30 | 5.73 | 6.31 | 0.58 | 10 | ||
2017-07-25 | 2017-06-30 | 4.41 | 5.04 | 0.63 | 14 | ||
2017-04-25 | 2017-03-31 | 4.97 | 5.2 | 0.23 | 4 | ||
2017-01-26 | 2016-12-31 | 4.96 | 5.04 | 0.08 | 1 | ||
2016-10-26 | 2016-09-30 | 4.97 | 5.19 | 0.22 | 4 | ||
2016-07-21 | 2016-06-30 | 4.67 | 5.21 | 0.54 | 11 | ||
2016-04-21 | 2016-03-31 | 4.47 | 4.79 | 0.32 | 7 | ||
2016-01-27 | 2015-12-31 | 4.08 | 4.5 | 0.42 | 10 | ||
2015-10-21 | 2015-09-30 | 3.8 | 4.48 | 0.68 | 17 | ||
2015-07-24 | 2015-06-30 | 4.1 | 4.22 | 0.12 | 2 | ||
2015-04-24 | 2015-03-31 | 3.91 | 3.82 | -0.09 | 2 | ||
2015-01-29 | 2014-12-31 | 3.78 | 4.09 | 0.31 | 8 | ||
2014-10-22 | 2014-09-30 | 3.46 | 3.8 | 0.34 | 9 | ||
2014-07-23 | 2014-06-30 | 2.83 | 3.34 | 0.51 | 18 | ||
2014-04-23 | 2014-03-31 | 2.55 | 2.47 | -0.08 | 3 | ||
2014-01-29 | 2013-12-31 | 2.28 | 2.34 | 0.06 | 2 | ||
2013-10-28 | 2013-09-30 | 2.1 | 2.35 | 0.25 | 11 | ||
2013-07-25 | 2013-06-30 | 1.93 | 2.3 | 0.37 | 19 | ||
2013-04-25 | 2013-03-31 | 1.61 | 1.97 | 0.36 | 22 | ||
2013-01-28 | 2012-12-31 | 1.46 | 1.4 | -0.06 | 4 | ||
2012-10-25 | 2012-09-30 | 1.6 | 1.91 | 0.31 | 19 | ||
2012-07-24 | 2012-06-30 | 1.56 | 1.82 | 0.26 | 16 | ||
2012-05-01 | 2012-03-31 | 1.48 | 1.4 | -0.08 | 5 | ||
2012-01-31 | 2011-12-31 | 1.49 | 1.51 | 0.02 | 1 | ||
2011-10-28 | 2011-09-30 | 1.53 | 1.61 | 0.08 | 5 | ||
2011-07-26 | 2011-06-30 | 1.37 | 1.36 | -0.01 | 0 | ||
2011-04-21 | 2011-03-31 | 1.41 | 1.43 | 0.02 | 1 | ||
2011-02-01 | 2010-12-31 | 1.23 | 1.42 | 0.19 | 15 | ||
2010-10-26 | 2010-09-30 | 1.22 | 1.35 | 0.13 | 10 | ||
2010-07-20 | 2010-06-30 | 1.12 | 1.31 | 0.19 | 16 | ||
2010-04-20 | 2010-03-31 | 1.13 | 1.08 | -0.05 | 4 | ||
2010-02-09 | 2009-12-31 | 1.05 | 1.2 | 0.15 | 14 | ||
2009-10-20 | 2009-09-30 | 1.04 | 1.12 | 0.08 | 7 | ||
2009-07-16 | 2009-06-30 | 0.68 | 0.75 | 0.07 | 10 | ||
2009-04-16 | 2009-03-31 | 1 | 1.05 | 0.05 | 5 | ||
2009-02-06 | 2008-12-31 | 0.93 | 0.93 | 0.0 | 0 | ||
2008-10-21 | 2008-09-30 | 0.9 | 0.98 | 0.08 | 8 | ||
2008-07-22 | 2008-06-30 | 0.85 | 0.91 | 0.06 | 7 | ||
2008-04-23 | 2008-03-31 | 0.79 | 0.83 | 0.04 | 5 | ||
2008-02-06 | 2007-12-31 | 0.8 | 0.89 | 0.09 | 11 | ||
2007-10-23 | 2007-09-30 | 0.65 | 0.58 | -0.07 | 10 | ||
2007-07-24 | 2007-06-30 | 0.63 | 0.7 | 0.07 | 11 | ||
2007-05-02 | 2007-03-31 | 0.61 | 0.59 | -0.02 | 3 | ||
2007-02-15 | 2006-12-31 | 0.55 | 0.53 | -0.02 | 3 | ||
2006-10-31 | 2006-09-30 | 0.49 | 0.6 | 0.11 | 22 | ||
2006-07-26 | 2006-06-30 | 0.49 | 0.57 | 0.08 | 16 | ||
2006-04-26 | 2006-03-31 | 0.48 | 0.55 | 0.07 | 14 | ||
2006-02-15 | 2005-12-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2005-10-26 | 2005-09-30 | 0.42 | 0.36 | -0.06 | 14 | ||
2005-07-26 | 2005-06-30 | 0.36 | 0.43 | 0.07 | 19 | ||
2005-04-27 | 2005-03-31 | 0.36 | 0.3 | -0.06 | 16 | ||
2005-02-07 | 2004-12-31 | 0.36 | 0.29 | -0.07 | 19 | ||
2004-10-27 | 2004-09-30 | 0.35 | 0.37 | 0.02 | 5 | ||
2004-07-28 | 2004-06-30 | 0.32 | 0.34 | 0.02 | 6 | ||
2004-04-30 | 2004-03-31 | 0.34 | 0.4 | 0.06 | 17 | ||
2004-03-02 | 2003-12-31 | 0.32 | 0.24 | -0.08 | 25 | ||
2003-10-14 | 2003-09-30 | 0.25 | 0.26 | 0.01 | 4 | ||
2003-07-17 | 2003-06-30 | 0.26 | 0.24 | -0.02 | 7 | ||
2003-04-15 | 2003-03-31 | 0.24 | 0.24 | 0.0 | 0 | ||
2003-01-30 | 2002-12-31 | 0.26 | 0.26 | 0.0 | 0 | ||
2002-10-16 | 2002-09-30 | 0.21 | 0.22 | 0.01 | 4 | ||
2002-07-17 | 2002-06-30 | 0.19 | 0.2 | 0.01 | 5 | ||
2002-04-18 | 2002-03-31 | 0.16 | 0.17 | 0.01 | 6 | ||
2002-01-29 | 2001-12-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2001-10-18 | 2001-09-30 | 0.16 | 0.16 | 0.0 | 0 | ||
2001-07-19 | 2001-06-30 | 0.15 | 0.15 | 0.0 | 0 | ||
2001-04-19 | 2001-03-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2001-01-29 | 2000-12-31 | 0.11 | 0.12 | 0.01 | 9 | ||
2000-10-16 | 2000-09-30 | 0.1 | 0.1 | 0.0 | 0 | ||
2000-07-18 | 2000-06-30 | 0.08 | 0.09 | 0.01 | 12 | ||
2000-04-20 | 2000-03-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2000-02-02 | 1999-12-31 | 0.07 | 0.05 | -0.02 | 28 | ||
1999-10-18 | 1999-09-30 | 0.07 | 0.07 | 0.0 | 0 | ||
1999-07-22 | 1999-06-30 | 0.13 | 0.13 | 0.0 | 0 | ||
1999-04-20 | 1999-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
1999-02-09 | 1998-12-31 | 0.04 | 0.05 | 0.01 | 25 | ||
1998-10-20 | 1998-09-30 | -0.01 | 0.02 | 0.03 | 300 | ||
1998-07-20 | 1998-06-30 | 0.06 | 0.09 | 0.03 | 50 | ||
1998-04-20 | 1998-03-31 | 0.01 | 0.03 | 0.02 | 200 | ||
1998-02-05 | 1997-12-31 | 0.05 | 0.06 | 0.01 | 20 | ||
1997-11-11 | 1997-09-30 | -0.06 | -0.08 | -0.02 | 33 | ||
1997-08-04 | 1997-06-30 | -0.07 | -0.04 | 0.03 | 42 | ||
1997-05-08 | 1997-03-31 | -0.05 | -0.02 | 0.03 | 60 | ||
1997-02-21 | 1996-12-31 | -0.02 | 0.01 | 0.03 | 150 | ||
1996-10-30 | 1996-09-30 | -0.05 | -0.04 | 0.01 | 20 | ||
1996-07-25 | 1996-06-30 | -0.04 | -0.04 | 0.0 | 0 | ||
1996-05-02 | 1996-03-31 | -0.06 | 0.02 | 0.08 | 133 | ||
1996-02-14 | 1995-12-31 | -0.03 | 0.02 | 0.05 | 166 | ||
1995-10-24 | 1995-09-30 | -0.05 | -0.05 | 0.0 | 0 |
Use Biogen in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.Biogen Pair Trading
Biogen Inc Pair Trading Analysis
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biogen position
In addition to having Biogen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
To fully project Biogen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biogen Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biogen's income statement, its balance sheet, and the statement of cash flows.